Table 3

Positional nucleotide usage frequencies in 113 Species

log(-C)
C1+G1
C3+G3
C2+G2
C2+T2
C1+T1
G2+T2
C3+T3
G1+T1
G3+T3
A3+C3
A1+C1
A3+G3
A2+C2
A1+G1
A2+G2
A2+T2
A3+T3
A1+T1

A1+T1
-100.0
-38.6
-38.3
-8.9
-7.4
-4.5
-3.6
-1.9
-0.5
0.5
1.9
3.6
4.5
7.4
8.9
38.3
38.6
100.0
A3+T3
-38.6
-100.0
-24.9
-4.6
-6.9
-2.7
-4.0
-0.4
-2.0
2.0
0.4
4.0
2.7
6.9
4.6
24.9
100.0
38.6
A2+T2
38.3
-24.9
-100.0
-7.1
-12.8
-2.9
-2.3
-1.1
-0.2
0.2
1.1
2.3
2.9
12.8
7.1
100.0
24.9
38.3
A2+G2
-8.9
-4.6
-7.1
-100.0
-3.0
-7.1
-5.4
-11.2
-0.5
0.5
11.2
5.4
7.1
3.0
100.0
7.1
4.6
8.9
A1+G1
-7.4
-6.9
-12.8
-3.0
-100.0
-0.2
-3.7
-0.2
-0.7
0.7
0.2
3.7
0.2
100.0
3.0
12.8
6.9
7.4
A2+C2
-4.5
-2.7
-2.6
-7.1
-0.2
-100.0
-0.8
-2.4
-0.2
0.2
2.4
0.8
100.0
0.2
7.1
2.9
2.7
4.5
A3+G3
-3.6
-4.0
-2.3
-5.4
-3.7
-0.8
-100.0
-1.3
-1.0
1.0
1.3
100.0
0.8
3.7
5.4
2.3
4.0
3.6
A1+C1
-1.9
-0.4
-1.1
-11.2
-0.2
-2.4
-1.3
-100.0
-0.6
0.6
100.0
1.3
2.4
0.2
11 2
1.1
0.4
1.9
A3+C3
-0.5
-2.0
-0.2
-0.5
-0.7
-0.2
-1.0
-0.6
-100.0
100.0
0.6
1.0
0.2
0.7
0.5
0.2
2.0
0.5


G3+T3
0.5
2.0
0.2
0.5
0.7
0.2
1.0
0.6
100.0
-100.0
-0.6
-1.0
-0.2
-0.7
-0.5
-0.2-
-2.0-
-0.5
G1+T1
1.9
0.4
1.1
11.2
0.2
2.4
1.3
100.0
0.6
-0.6
-100.0
-1.3
-2.4
-0.2
-11.2
-1.1
-0.4
-1.9
C3+T3
3.6
4.0
2.3
5.4
3.7
0.8
100.0
1.3
1.0
-1.0
-1.3
-100.0
-0.8
-3.7
-5.4
2.3
4.0
-3.6
G2+T2
4.5
2.7
2.9
7.1
0.2
100.0
0.8
2.4
0.2
-0.2
-2.4
-0.8
-100.0
-0.2
-7.1
-2.9
-2.7
-4.5
C1+T1
7.4
6.9
12.8
3.0
100.0
0.2
3.7
0.2
0.7
-0.7
-0.2
-3.7
-0.2
-100.0
-3.0
-12.8
-6.9
-7.4
C2+T2
8.9
4.6
7.1
100.0
3.0
7.1
5.4
11.2
0.5
-0.5
-11.2
-5.4
-7.1
-3.0
-100.0
-7.1
-4.6
-8.9
C2+G2
38.3
24.9
100.0
7.1
12.8
2.9
2.3
1.1
0.2
-0.2
-1.1
-2.3
-2.9
-12.8
-7.1
-100.0
-24.9
-38.3
C3+G3
38.6
100.0
24.9
4.6
6.9
2.7
4.0
0.4
2.0
-2.0
-0.4
-4.0
-2.7
-6.9
-4.6
-24.9
-100.0
-38.6
C1+G1
100.0
38.6
38.3
8.9
7.4
4.5
3.6
1.9
0.5
-0.5
-1.9
-3.6
-4.5
-7.4
-8.9
-38.3
-38.6
-100.0

C: Significance of correlation. – sign was added to negative correlations. log (-0) was regarded to be 100

Biro Theoretical Biology and Medical Modelling 2008 5:16   doi:10.1186/1742-4682-5-16